10 results on '"Molony DA"'
Search Results
2. In chronic HF, empagliflozin reduced a composite of CV death or HF hospitalization across kidney risk categories.
3. In hypertension not treated with medications, renal denervation vs. sham reduced daytime ambulatory SBP at 2 mo.
4. KDIGO provided recommendations on SGLT2 inhibitors and nonsteroidal MRAs in patients with diabetes and CKD.
5. In afebrile men with UTIs, 7 d of ciprofloxacin or trimethoprim-sulfamethoxazole was noninferior to 14 d.
6. In ANCA-associated vasculitis, avacopan was superior to prednisone taper for sustained remission.
7. In CKD, dapagliflozin reduced a composite of eGFR decline, end-stage kidney disease, or CV or renal mortality.
8. Review: Dapagliflozin increases, and empagliflozin reduces, adverse renal events in type 2 diabetes.
9. ACP Journal Club: the CKD-EPI equation for eGFR predicted adverse outcomes after PCI better than other equations.
10. ACP Journal Club. Young adults with persistent, asymptomatic, isolated microscopic hematuria were at increased risk for ESRD.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.